基于孟德尔随机化与多维微生物组整合分析的肠道菌群与慢性胰腺炎因果关联研究
作者:
通讯作者:
作者单位:

1哈尔滨医科大学附属第一医院 胰胆外科,黑龙江 哈尔滨 150081;2哈尔滨医科大学 肝脾外科教育部重点实验室, 黑龙江 哈尔滨 150081

作者简介:

王凤仪,哈尔滨医科大学附属第一医院/哈尔滨医科大学硕士研究生,主要从事慢性胰腺炎方面的研究。

基金项目:

国家自然科学基金资助项目(82270666);中国科协青年科技人才托举工程基金资助项目(2023QNRC001);黑龙江省自然科学基金资助项目(YQ2023H007);哈尔滨医科大学附属第一医院杰出青年科学基金资助项目(2024JQ16)。


Causal associations between gut microbiota and chronic pancreatitis: an integrative analysis using Mendelian randomization and multi-omics data
Author:
Affiliation:

1Department of Pancreatic and Biliary Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin 150081, China;2Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Harbin 150007, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    背景与目的 肠道微生物紊乱被认为参与慢性胰腺炎(CP)的发生发展,但其因果关系尚未明确。本研究基于孟德尔随机化(MR)联合多维度微生物组学分析,系统评估肠道菌群与CP的因果关联,并筛选关键菌属。方法 基于大规模全基因组关联研究(GWAS)汇总数据,采用双样本MR分析评估属水平肠道微生物对CP及血浆代谢物的因果效应。同步收集CP患者及小鼠模型粪便样本,进行16S rRNA测序分析菌群结构差异,并结合公共数据库数据进行交叉验证,以筛选与CP密切相关的关键菌属。结果 MR分析识别出8个与CP风险存在潜在因果关联的菌属,其中乳球菌属、考拉杆菌属、罗斯氏菌属等为潜在危险因素,而甲烷短杆菌属、毛螺菌科FCS020群等表现为保护因素。进一步发现22种血浆代谢物与CP显著相关。16S rRNA测序显示,CP患者及模型小鼠均存在明显肠道菌群失调,分别鉴定出59个和52个差异菌属。交叉验证结果表明,乳球菌属在MR分析、人群样本(P=0.008)及小鼠模型(P=0.003)中均具有一致性关联,为最关键候选菌属。结论 本研究整合遗传因果推断与多维微生物组证据,证实肠道菌群紊乱与CP之间存在潜在因果关系。乳球菌属可能在CP发生早期发挥促发作用,而在疾病进展阶段呈现耗竭,提示其在不同阶段具有动态调控作用。

    Abstract:

    Background and Aims Gut microbiota dysbiosis is implicated in the pathogenesis of chronic pancreatitis (CP), yet its causal relationship remains unclear. This study aimed to systematically evaluate the causal associations between gut microbiota and CP using Mendelian randomization (MR) integrated with multi-dimensional microbiome analyses.Methods Summary-level data from large-scale genome-wide association studies (GWAS) were used to perform two-sample MR analyses to assess the causal effects of gut microbial genera on CP and plasma metabolites. Fecal samples from CP patients and mouse models were subjected to 16S rRNA sequencing to characterize microbial alterations. Public datasets were incorporated for cross-validation to identify key CP-associated genera.Results MR analysis identified eight microbial genera with potential causal associations with CP. Lactococcus, Phascolarctobacterium, and Roseburia were identified as potential risk factors, whereas Methanobrevibacter and Lachnospiraceae FCS020 group showed protective effects. Additionally, 22 plasma metabolites were associated with CP. 16S rRNA sequencing revealed significant microbial dysbiosis, with 59 and 52 differentially abundant genera identified in humans and mice, respectively. Cross-validation consistently identified Lactococcus as the most critical genus across MR, human (P=0.008), and mouse (P=0.003) datasets.Conclusion By integrating genetic causal inference with microbiome profiling, this study provides evidence supporting a causal link between gut microbiota and CP. Lactococcus may exert stage-dependent effects, acting as a potential risk factor in disease susceptibility while being depleted during disease progression.

    图1 肠道微生物对CP的MR分析结果森林图Fig.1 Forest plot of MR analysis for the causal effects of gut microbiota on CP
    图2 CP组对照组肠道微生物组成的比较 A:α多样性比较分析;B:β多样性比较分析;C:肠道菌群属水平主要细菌分类群的相对丰度堆叠图;D:组间显著差异菌属的相对丰度热图;E:组间显著差异菌属的相对丰度火山图;F:16s显著差异菌与MR分析结果韦恩图;G:MR识别的7个因果关联菌属在独立验证队列中的丰度热图Fig.2 Comparison of gut microbiota composition between CP and control groups A: α diversity analysis; B: β diversity analysis; C: Relative abundance of major genera (stacked bar plot); D: Heatmap of differentially abundant genera; E: Volcano plot of differential genera; F: Venn diagram of overlapping genera between 16S and MR analyses; G: Heatmap of MR-identified genera in validation cohort
    图3 CP组与对照组小鼠肠道微生物组成的比较 A:胰腺组织HE染色、Masson染色以及α-SMA染色代表性图(比例尺:200 μm);B:对照组与CP组胰腺病理学评分的定量比较;C:胶原沉积定量分析;D:α-SMA表达定量分析;E:血清淀粉酶表达的定量分析;F:血清脂肪酶表达的定量分析;G:α多样性比较分析;H:β多样性比较分析;I:肠道菌群属水平主要细菌分类群的相对丰度堆叠图;J:组间显著差异菌属的相对丰度热图;K:组间显著差异菌属的相对丰度火山图;L:16s rRNA与MR分析结果韦恩图Fig.3 Comparison of gut microbiota and pancreatic pathology between CP and control mice A: Representative HE, Masson, and α-SMA staining (scale bar: 200 μm); B: Histopathological score; C: Collagen deposition quantification; D: α-SMA expression quantification; E: Serum amylase levels; F: Serum lipase levels; G: α diversity; H: β diversity; I: Relative abundance of major genera; J: Heatmap of differential genera; K: Volcano plot; L: Venn diagram of MR and 16S results
    图4 代谢物对CP相关差异代谢物 A:代谢物对CP风险的MR分析结果;B:差异代谢物的KEGG通路富集分析结果Fig.4 Causal associations between plasma metabolites and CP A: MR analysis results of metabolites for CP risk; B: KEGG pathway enrichment analysis
    表 1 肠道菌群与CP属水平工具变量强度与多效性评估Table 1 Strength and pleiotropy assessment of instrumental variables for gut microbiota at the genus level
    参考文献
    相似文献
    引证文献
引用本文

王凤仪,隋宇航,孙备,李乐.基于孟德尔随机化与多维微生物组整合分析的肠道菌群与慢性胰腺炎因果关联研究[J].中国普通外科杂志,2026,35(3):470-479.
DOI:10.7659/j. issn.1005-6947.250643

复制
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2025-11-17
  • 最后修改日期:2026-03-18
  • 录用日期:
  • 在线发布日期: 2026-05-11